Epidemiological data and medical care situation of patients with chronic inflammatory diseases in Germany: Real-world evidence on prevalence, disease combinations, care

被引:0
|
作者
Riemekasten, Gabriela [1 ]
Schmelz, Renate [2 ]
Schaekel, Knut [3 ]
Thaci, Diamant [4 ]
Schreiber, Stefan [5 ,6 ]
Roecken, Marit [7 ]
Bartz, Holger [7 ]
Ploner, Tina [8 ]
Liao, Ximing [8 ]
Weber, Valeria [9 ]
Manz, Karina C. [9 ]
Burkhardt, Harald [10 ]
Leipe, Jan [11 ]
机构
[1] Univ klinikum Schleswig Holstein, Klin Rheumatol & Klin Immunol, Lubeck, Germany
[2] Univ klinikum Carl Gustav Carus Dresden, Med Klin & Poliklin 1, Fetscherstr 74, D-01307 Dresden, Germany
[3] Univ klinikum Heidelberg, IZEH Interdisziplinares Zent chron entzundl Erkran, Heidelberg, Germany
[4] Univ Lubeck, Inst & Exzellenzzentrum Entzundungs Med, Lubeck, Germany
[5] Univ klinikum Schleswig Holstein, Klin Innere Med 1, Campus Kiel, Kiel, Germany
[6] Univ klinikum Schleswig Holstein, Inst Klin Molekularbiol, Campus Kiel, Kiel, Germany
[7] Janssen Cilag GmbH, Neuss, Germany
[8] InGef Inst Angew Gesundheitsforschung Berlin GmbH, Berlin, Germany
[9] IGES Inst GmbH, Berlin, Germany
[10] Univ klinikum Frankfurt, Goethe Univ Frankfurt Main, Fraunhofer Inst Translationale Med & Pharmakol ITM, Med Klin II Rheumatol, Frankfurt, Germany
[11] Univ klinikum Mannheim, V Med Klin, Sekt Rheumatol, Mannheim, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2024年 / 83卷 / 07期
关键词
Immune-mediated inflammatory diseases; Health insurances accounting data; Retrospective cross-sectional analysis; Multidisciplinary approach; Efficiency of care; PSORIATIC-ARTHRITIS; BOWEL-DISEASE;
D O I
10.1007/s00393-023-01459-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic inflammatory diseases (immune-mediated inflammatory diseases, IMID) can overlap or occur simultaneously due to clinical similarities. The resulting utilization of heathcare structures has not yet been investigated across disciplines but is of potential importance for optimizing the treatment of patients with IMID.<br />Aim of the work: Analysis of epidemiological data including utilization of care services in patients with selected IMIDs: psoriasis, psoriatic arthritis (PsA), rheumatoid arthritis (RA), ankylosing spondylitis, ulcerative colitis, Crohn's disease and connective tissue disease.<br />Material and methods: In a retrospective cross-sectional analysis based on health insurances accounting data with a sample of approximately 4 million insured persons, the prevalence of the abovementioned IMID and the frequency of IMID combinations were analyzed based on documented diagnoses (ICD-10 GM). The frequency of hospitalizations and utilization of outpatient physician contacts was recorded in predefined specialist disciplines (general medicine, dermatology, gastroenterology, rheumatology) and compared with an age-adjusted and gender-adjusted reference population.<br />Results: A total of 188,440 patients had at least 1 of the IMID diagnoses analyzed (4.7%), with an age peak of 61-70 years. The highest prevalence was observed for psoriasis (1.85%), followed by rheumatoid arthritis (1.38%). Combinations with at least one other IMID were relatively common (29%), with this being most common in patients with psoriatic arthritis (82.9%, of which 68.2% had psoriasis), followed by ankylosing spondylitis (27.5%) and Crohn's disease (21.6%). Compared to the reference population, patients with IMID were hospitalized more often and more frequently utilized the outpatient disciplines.<br />Discussion: The study results describe that IMIDs occur in combination and that the patients make comparatively more use of care structures of different disciplines. A multidisciplinary approach could increase the efficiency of care; an evaluation is still pending.
引用
收藏
页码:578 / 586
页数:9
相关论文
共 50 条
  • [21] Correction: Real-World Status of Medical Care and Treatment of Chronic Obstructive Pulmonary Disease by Respiratory Specialists in Japan
    Shu Hashimoto
    Ryoko Sorimachi
    Naoyuki Makita
    Naoki Tashiro
    Satoko Sugaya
    Yoshifumi Arita
    Masakazu Ichinose
    Advances in Therapy, 2022, 39 : 4522 - 4522
  • [22] Use of azilsartan medoxomil in the primary-care setting in Germany: A real-world evidence study
    Ehlken, Birgit
    Shlaen, Margarita
    de Torres, Maria del Pilar Lopez Fuensalida
    Hisada, Michie
    Bennett, Dimitri
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (06) : 275 - 283
  • [23] The prediagnostic general practitioner care of sarcoma patients: A real-world data study
    Holthuis, Emily I.
    van der Graaf, Winette T. A.
    Drabbe, Cas
    van Houdt, Winan J.
    Schrage, Yvonne M.
    Hartman, Tim C. Olde
    Uijen, Annemarie A.
    Bos, Isabelle
    Heins, Marianne
    Husson, Olga
    JOURNAL OF SURGICAL ONCOLOGY, 2024, 130 (02) : 265 - 275
  • [24] Primary care referral patterns for patients with asthma: analysis of real-world data
    Ortega, Hector
    Bharmal, Nazleen
    Khatri, Sumita
    JOURNAL OF ASTHMA, 2023, 60 (03) : 609 - 615
  • [25] MULTIMORBIDITY AND TREATMENT OUTCOMES IN ADVANCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): REAL-WORLD EVIDENCE FROM A NATIONAL HEALTH CARE DATA SET
    Gutfraind, Alexander
    Alves, Paula
    Chong, Stephanie
    Shi, Jingpu
    Knott, Charlotte
    Kale, Rajas
    Jankovic, Ivana
    Norgeot, Beau
    CHEST, 2023, 164 (04) : 4964A - 4965A
  • [26] Health Care Resource Use and Cost Burden of Chronic Kidney Disease in Patients With Chronic Liver Disease: A Real-World Claims Analysis
    Rustgi, Vinod K.
    Li, You
    John, Tina
    Catalano, Carolyn
    Elsaid, Mohamed, I
    HEPATOLOGY COMMUNICATIONS, 2020, 4 (10) : 1404 - 1418
  • [27] Epidemiological research and treatment data analysis for chronic inflammatory bowel diseases Improvement in care of children and adolescents
    de Laffolie, Jan
    MONATSSCHRIFT KINDERHEILKUNDE, 2020, 168 (04) : 298 - 313
  • [28] Utilizing Real-World Evidence (RWE) to Improve Care in Chronic Lymphocytic Leukemia: Challenges and Opportunities
    Prioty Islam
    Anthony R. Mato
    Current Hematologic Malignancy Reports, 2020, 15 : 254 - 260
  • [29] Epidemiology and health care utilization of patients suffering from Huntington’s disease in Germany: real world evidence based on German claims data
    Christoph Ohlmeier
    Kai-Uwe Saum
    Wolfgang Galetzka
    Dominik Beier
    Holger Gothe
    BMC Neurology, 19
  • [30] Is it time to use real-world data from primary care in Alzheimer’s disease?
    Anna Ponjoan
    Josep Garre-Olmo
    Jordi Blanch
    Ester Fages
    Lia Alves-Cabratosa
    Ruth Martí-Lluch
    Marc Comas-Cufí
    Dídac Parramon
    María Garcia-Gil
    Rafel Ramos
    Alzheimer's Research & Therapy, 12